Press Release · Justice News
Justice Department’s Civil Division and the Department of Health & Human Services Announce Anti-Fraud Healthcare Self-Disclosure Pilot Program
Distributed by The Digest Lab · Originally issued via U.S. Department of Justice
MENU News
Archived Press Releases
Press Release Justice Department’s Civil Division and the Department of Health & Human Services Announce Anti-Fraud Healthcare Self-Disclosure Pilot Program Thursday, October 22, 2026 Share
For Immediate Release
Office of Public Affairs
The Six-Month Pilot Program Provides a Pathway for Legitimate Healthcare Companies to Resolve Potential False Claims Act Violations
The Department of Justice Civil Division has partnered with the Department of Health and Human Services (HHS) to launch a Healthcare False Claims Act Self-Disclosure Pilot Program (FCA SDPP), which is designed to give healthcare companies a way to quickly resolve past misconduct by self-disclosing potential violations of the federal False Claims Act (FCA) and to prioritize the government’s resources toward recalcitrant actors. This civil pilot program builds on longstanding Department principles, discussed further here and here, to promote predictable and efficient resolution of corporate misconduct while recovering damages and penalties for taxpayers.[1]
“Voluntary self-disclosure is a powerful indicator of a company’s commitment to compliance and accountability,” said Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division. “This pilot program offers a favorable resolution framework to companies that want to take responsibility for past conduct while allowing the Department to concentrate resources on those who deliberately exploit our healthcare system. But for companies unwilling to take accountability, the Civil Division, in partnership with whistleblowers, will root out the fraud.”
“By providing predictable and clear incentives for self-disclosure, this pilot program offers responsible companies an opportunity to move forward as stronger partners to federal healthcare programs,” said Deputy Assistant Attorney General Brenna Jenny of the Justice Department’s Civil Division. “When companies identify misconduct and take meaningful steps to fix the problem and repay the government plus penalties, the Department will take those actions into account in determining appropriate resolutions.”
Participants must describe all relevant details relating to the disclosing company’s conduct that potentially violates the federal FCA and produce documents sufficient to fully reflect the nature, terms, and operation of the disclosed potential FCA violations. Self-disclosing companies must describe the remedial actions they have taken and make a financial repayment with a 1.25–1.6 multiplier. The multiplier applied will vary based on factors such as the timeliness of the self-disclosure, the duration and scope of the misconduct, the involvement of senior leadership, the financial benefit to the disclosing company, and whether the disclosing company has successor liability for the misconduct but promptly remediated. In exchange, companies will receive a coordinated civil release from liability under the federal False Claims Act and certain HHS administrative authorities.
Companies may submit self-disclosures electronically to [email protected]. The FCA SDPP will accept submissions through April 22, 2027. Late and incomplete submissions will not be reviewed.
Note: A copy of the FCA SDPP protocol is available here.
[1] The FCA SDPP is a pilot program available for conduct that potentially violates civil laws. A company seeking to self-disclose potential criminal conduct related to health care must disclose that conduct to the Justice Department’s National Fraud Enforcement Division pursuant to the National Fraud Enforcement Division and HHS-OIG Policy on Coordination of Voluntary Self-Disclosure in Health Care Fraud Matters. A company that makes a voluntary self-disclosure of criminal matters to the Fraud Division within the meaning of the CEP need not make a duplicative submission to [email protected]. Where a company also seeks a civil FCA release through the FCA SDPP, supplementation of its Fraud Division disclosure will be requested only to the extent necessary.
Updated October 22, 2026 Topics False Claims Act Fraud Component Civil Division Press Release Number: 26-1218Related Content
Press ReleaseSomerset Lifesciences Inc. Agrees to Pay $4M to Resolve Allegations of Causing Medicare to Pay Claims for its Mislabeled Generic DrugSomerset Lifesciences Inc. (Somerset) has agreed to pay $4 million to resolve common law claims for causing Medicare Part D (Medicare) to pay for its prescription-only (Rx-only) generic drug Olopatadine...
October 16, 2026 Press ReleaseCVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal GovernmentCVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through...
October 13, 2026 Press ReleaseHeal 360 Clinics and Owner Agree to Pay $20M to Resolve False Claims Act Allegations of Billing False Claims to the COVID-19 Uninsured Program for Services Not RenderedHeal 360 Urgent Care PLLC, Heal 360 Primary Care PLLC (together “Heal 360”) and their owner, Dr. Mohammed Amer Mohiuddin (Mohiuddin), have agreed to pay the United States $20 million...
October 7, 2026